Clinical Trial Update: Idiopathic Dilated Cardiomyopathy

View source ↗

Summary

This update reports the completed status of a National Heart, Lung, and Blood Institute trial investigating idiopathic dilated cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Dilated Cardiomyopathy

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Heart Diseases, Cardiomyopathy, Congestive | Status: COMPLETED